Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

Conditions

• Lymphoma, Non-Hodgkin
• Multiple Myeloma
• Advanced Solid Tumors

Interventions

• DRUG: Olaparib
• DRUG: Dasatinib
• DRUG: Nivolumab plus Ipilimumab
• DRUG: Axitinib
• DRUG: Bosutinib
• DRUG: Crizotinib
• DRUG: Palbociclib
• DRUG: Sunitinib
• DRUG: Temsirolimus
• DRUG: Erlotinib
• DRUG: Trastuzumab plus Pertuzumab
• DRUG: Vemurafenib plus Cobimetinib
• DRUG: Vismodegib
• DRUG: Tucatinib

Sponsor

Canadian Cancer Trials Group

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]